<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: hepg2 cells</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>A potential drug for liver carcinoma</title>
   	 <description>Looking for efficient anti-tumor drugs is a hot research area. Chrysin (5,7-dihydroxy flavone), a natural widely-distributed flavonoid, has been reported to have many different biological activities such as anti-oxidant, anti-virus, antidiabetogenic activity and clear anxiolytic effect. However, Chrysin is limited in its clinical application because of its modest absorption in the intestine and rapid in vivo glycosylation. To improve the biological activity of chrysin, a number of its derivatives have been prepared for biological testing. 5-allyl-7-gen-difluoromethylenechrysin (ADFMChR) is one of them.</description>
     <link>http://phys.org/news162214436.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 22 May 2009 12:35:56 EST</pubDate>
	 <guid isPermaLink="false">news162214436</guid>
	 
</item>
<item>
     <title>Farnesoid X receptor regulates cystathionase</title>
   	 <description>The expression and activity of Cystathionase is reduced in rodent models of liver injury, leading to hyper-homocysteinemia and impaired generation of hydrogen sulphide, two factors that contribute to endothelial dysfunction and increased intrahepatic resistance.</description>
     <link>http://phys.org/news161428443.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 May 2009 10:20:04 EST</pubDate>
	 <guid isPermaLink="false">news161428443</guid>
	 
</item>


</channel>
</rss>
